Carrageenans and the Carrageenan-Echinochrome Complex as Anti-SARS-CoV-2 Agents
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136175 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Natalya V Krylova und 7 weiteren Autor:innen. Beteiligte Einrichtung: G.P. Somov Institute of Epidemiology and Microbiology, Rospotrebnadzor, 690087 Vladivostok, Russia. Hauptthemen laut MEDLINE: Carrageenan, SARS-CoV-2, Antiviral Agents, COVID-19 Drug Treatment. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, the Rospotrebnadzor of the Russian Federation in the framework of the implementation of the state task, Rospotrebnadzor of the Russian Federation in the framework of the implementation of the state task.
Abstract (Originalsprache)
The diversity of structural types of carrageenans (CRGs)—sulfated polysaccharides of red algae—determines their different biological activities. The different types of CRGs (kappa, lambda, kappa/beta-CRGs) were isolated from the red algae of the Pacific coast. Molecular docking was performed to determine potential interactions of CRGs with the receptor-binding domain (RBD) of SARS-CoV-2 and its cellular receptor—angiotensin—converting enzyme type 2 (ACE2). CRGs interacted with ACE2 and RBD via hydrogen bonding and ionic interactions. The strongest binding affinity of CRGs and ACE2 was observed for kappa-CRG. Molecular docking was confirmed by results studying the effects of CRGs against SARS-CoV-2 in vitro. The ability of CRGs, as well as the complex CRG with sea urchin echinochrome (Ech), to inhibit SARS-CoV-2 replication in Vero E6 cells was studied using cytopathic effect (CPE) inhibition and RT-PCR assays. The simultaneous treatment of cells with CRGs and the virus revealed that kappa-CRG exhibited the most significant antiviral effect among all the polysaccharides, with a selective index (SI) of 33. The kappa-CRG/Ech complex exhibited the highest virucidal effect on SARS-CoV-2 particles with an SI above 70 (more than two times higher than that of CRG and Ech) and reduced viral RNA levels by 45% (IC = 45%). Our results illustrate that CRGs and kappa-CRG/Ech complex can act as protective agents against SARS-CoV-2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- G.P. Somov Institute of Epidemiology and Microbiology, Rospotrebnadzor, 690087 Vladivostok, Russia.
- G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far-Eastern Branch of the Russian Academy of Science, 690022 Vladivostok, Russia.
ORCID-Profile: Natalya V Krylova, Galina N Likhatskaya, Olga V Iunikhina
Förderung
- Russian Science Foundation
- the Rospotrebnadzor of the Russian Federation in the framework of the implementation of the state task
- Rospotrebnadzor of the Russian Federation in the framework of the implementation of the state task
Zitieren
APA
Krylova, N. V., Kravchenko, A. O., Likhatskaya, G. N., Iunikhina, O. V., Glazunov, V. P., Zaporozhets, T. S., Shchelkanov, M. Y., & Yermak, I. M. (2025). Carrageenans and the Carrageenan-Echinochrome Complex as Anti-SARS-CoV-2 Agents. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136175
Vancouver
Krylova NV, Kravchenko AO, Likhatskaya GN, Iunikhina OV, Glazunov VP, Zaporozhets TS, et al. Carrageenans and the Carrageenan-Echinochrome Complex as Anti-SARS-CoV-2 Agents. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136175
BibTeX
@article{Krylova2025,
author = {Krylova, Natalya V and Kravchenko, Anna O and Likhatskaya, Galina N and Iunikhina, Olga V and Glazunov, Valery P and Zaporozhets, Tatyana S and Shchelkanov, Mikhail Y and Yermak, Irina M},
title = {Carrageenans and the Carrageenan-Echinochrome Complex as Anti-SARS-CoV-2 Agents},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136175}
}
EUVIMED